Ads
related to: biotechnology biotechonlinelibrary.wiley.com has been visited by 10K+ users in the past month
Search results
Activation Capital Introduces 'Frontier BioHealth' to Catalyze Life Science Startups
FOX 59 Indianapolis· 5 days agoEmerging pharmaceutical, biotechnology, medical device, and health-focused consumer products...
St. Louis firm, backed by $200M in funding, gets regulatory nods to ‘expedite’ review of cancer drug...
The Business Journals· 20 hours agoSt. Louis biotechnology startup Wugen, which has raised more than $200 million in venture funding as...
EXCLUSIVE: Coya Therapeutics, Focused On Neurodegenerative Diseases Has Gained 70% Since IPO; CEO...
Benzinga via Yahoo Finance· 1 day agoCoya Therapeutics Inc (NASDAQ:COYA) is a clinical-stage biotechnology company developing treatments...
That viral video showing a head transplant is a fake. But it might be real someday.
Technology Review· 5 days agoMany proponents of longer life spans will...your brain holds out. The idea was strongly endorsed in...
Tyligand Bioscience Announces First Patient Dosed in Phase 1/2 Clinical Trial of TSN1611, a...
NBC 10 - FOX 14 Monroe· 4 days agoTyligand Bioscience, a clinical-stage biotechnology company focused on the discovery and development of innovative cancer therapies, announced that the first patient had been ...
RevolKa Signed Master Service Agreement with Daiichi Sankyo
Benzinga· 15 hours agoRevolKa will create highly functional proteins by using AI-driven platform RevolKa Ltd., a venture-backed biotech company providing a game-changing protein engineering technology platform (Norio Hamamatsu, President
Temple Street Biotech Initiates Groundbreaking Therapeutic Antibody for Alzheimer's Disease
NBC 17 Raleigh· 7 days agoTemple Street Biotech is proud to announce the initiation of a pioneering therapeutic antibody targeting prion protein for the treatment of Alzheimer's disease. This project ...
Unveiling Moderna (MRNA)'s Value: Is It Really Priced Right? A C
Guru Focus· 57 minutes agoFounded in 2010 and going public in December 2018, Moderna is a commercial-stage biotech leader that leveraged its mRNA technology to develop a COVID-19 vaccine authorized ...
Cytokinetics secures up to $575M in royalty deal, frustrating investors
BioPharma Dive via Yahoo Finance· 5 days agoThe biotech’s decision to give Royalty Pharma a greater share of future drug sales suggests a lower...
Alligator Bioscience To Present Positive Phase 2 Mitazalimab Data in Pancreatic Cancer at 2024 ASCO...
Digital Journal· 5 days agoOPTIMIZE-1 study results showed confirmed ORR of 40.4%, unconfirmed ORR of 50.9% and DCR of 79% in 57 evaluable patients with chemotherapy-naïve mPDACThe encouraging duration of response (median ...
